Tag

COVID-19

The Importance of Leadership in Manufacturing
MANUFACTURING, MANUFACTURING, VIDEO

The Importance of Leadership in Manufacturing

Illustrating the importance of leaders during crises and rapidly evolving circumstances. What have we learned in the last two years? Offering new ideas and best practices to do reviews remotely and win buy-in from a distributed workforce How has workforce culture evolved, and what initiatives are we moving forward with to shape and influence the culture we need for the future? What should other organizations leadership take away from our experience? — Brian Krinock SVP, Vehicle Manufacturing & Production Engineering Toyota Brian Krinock is a senior vice-president at Toyota Motor North America. He oversees the manufacturing operations of eight vehicle…

Continue reading
The Labor and Talent We Need Now, Tomorrow, and in the Decades to Come
MANUFACTURING, MANUFACTURING, VIDEO

The Labor and Talent We Need Now, Tomorrow, and in the Decades to Come

Who are the next generation of manufacturing professionals? Are we attracting and developing the talent we are going to need? Discussing how broadly speaking COVID-19 has changed the way people think about their work-life goals with a particular focus on what has changed for our existing workforce Walking through examples of internships, apprenticeships, and collaborations with educational institutions that deepen the pool of skilled workers Identifying the top-performers of the future and making special efforts to grow their skill sets, abilities, and responsibilities over time Novel approaches to cross-training, mentoring, coaching, and career management to keep your staff satisfied and…

Continue reading
Leadership Strategies to Survive Excel in a COVID and Post-COVID World
MANUFACTURING, MANUFACTURING, VIDEO

Leadership Strategies to Survive Excel in a COVID and Post-COVID World

What are some of the unexpected lessons —good and bad— we have taken away from 2020 and 2021? Discussing examples of innovations created by necessity during the global pandemic that will continue on long into the future Taking this chapter in our working lives as an opportunity to re-evaluate, reconsider, and rethink some of the manufacturing processes and strategies we had in place before COVID-19 — Maciej Stawicki VP Global Manufacturing Procter & Gamble Maciej Stawicki is the P&G Global Manufacturing Vice President. He owns the Integrated Work System capability building program for 113 manufacturing sites across the globe. Stawicki…

Continue reading
Panel: Looking Backwards, Looking Forwards —How Did the Last Two Years Change Us?
MANUFACTURING, MANUFACTURING, VIDEO

Panel: Looking Backwards, Looking Forwards —How Did the Last Two Years Change Us?

How has working through a global pandemic impacted the way we do business? Taking stock of how we changed and why we changed. What are some of the net positives? What are some of the things where we do want to return to how things used to be? Reviewing where our organizations were five years ago and where we planned to be today, how much has COVID-19 changed the trajectory of our journeys? What are some of the lessons learned that we plan to take with us into the future? Are manufacturing leaders stronger for this experience? Where do we…

Continue reading
What Lessons Should Pharmaceutical Manufacturers Take Away from Operation Warp Speed?
LIFE SCIENCES, LIFE SCIENCES, VIDEO

What Lessons Should Pharmaceutical Manufacturers Take Away from Operation Warp Speed?

Offering an overview of the public-private partnership that facilitated and accelerated the development, manufacturing, and distribution of COVID-19 vaccines, therapeutics, and diagnostics During the pandemic our industry faced crisis and achieved the seemingly impossible. What drives an extraordinary performance? Building stronger bonds of communication, collaboration, and coordination between industry partners and regulators to serve patients better Discussing which parts of our experience with Operation Warp Speed can be built into our industry’s long-term future — Carlo de Notaristefani Lead, Manufacturing & Supply Chain Advisor Operation Warp Speed An international operations executive with global technical, operational, and P&L experience, Carlo has…

Continue reading
The Things We Can Achieve and Our Shared Journey Along the Way
LIFE SCIENCES, LIFE SCIENCES, VIDEO

The Things We Can Achieve and Our Shared Journey Along the Way

How the pandemic has impacted innovation, technology, people and our ways of working and thinking Understanding current capabilities and where we need to be collectively headed as a community of pharmaceutical manufacturers Strategies that compel and empower us to move beyond past constraints and set new, ambitious goals for the future Thinking beyond the data to find purpose and meaningful connections for people — Arleen Paulino SVP Global Manufacturing Amgen Arleen Paulino, Senior Vice President, Manufacturing, leads Amgen’s commercial manufacturing organization. Prior to this role, Paulino served as vice president, Site Operations at Amgen Singapore Manufacturing from 2016 to 2018,…

Continue reading
Moving at the Speed of Science
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Moving at the Speed of Science

Science Will Win: Pfizer’s 5-point plan and industry pledge to finding solutions to the global health crisis Pushing the boundaries of what’s possible: Moving at Lightspeed Hope Changes Lives: The development, manufacture, and distribution of the COVID-19 vaccine and oral treatment Key takeaway: Making the Impossible Possible — John Kelly VP, Quality Operations and Environment, Health & Safety, Pfizer Global Supply Pfizer Inc. John F. Kelly is Vice President, Quality Operations and Environment, Health & Safety, responsible for leading the overall Quality function for Pfizer and for leading global EHS across the Company.  John is a member of the PGS…

Continue reading
Sanofi Manufacturing Transformation: Turning Science into Reality for Patients
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Sanofi Manufacturing Transformation: Turning Science into Reality for Patients

Our new purpose: we chase the miracles of science to improve people’s lives Our race to make available breakthrough treatments & vaccines for patients supported by diverse modalities: accelerate product launches and optimize our asset performance Our ambition to develop a network of Factories of the Future Our response to COVID: Operating with a global Supply Chain in a changing environment impacted by COVID and leveraging our assets to fight against the pandemic — Brendan O’Callaghan EVP, Global Industrial Affairs Sanofi Brendan O’Callaghan leads an international network of manufacturing and distribution sites. His ambition is to enable successful commercialization of…

Continue reading
Creating and Maintaining a Resilient Supply Chain: Lessons Learned from a Pandemic
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Creating and Maintaining a Resilient Supply Chain: Lessons Learned from a Pandemic

How do you define a supply chain? The what, the who, the where and the how Risk categorization Impact, probability and detectability Risk approach Detection, prevention/mitigation and response Near-miss lessons learned — Ken Kent SVP, Chemical Development and Manufacturing Operations Gilead Ken is the Senior Vice President of Chemical Development and Manufacturing Operations. He is responsible for Gilead’s entire drug substance supply and oversees process R&D functions in Foster City and Edmonton, as well as internal and outsourced manufacturing. He played a critical role leading CDMO in sourcing ingredients and scaling up production of remdesivir drug substance, to speed up…

Continue reading
Idea to Performance: The Impossible Journey
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Idea to Performance: The Impossible Journey

Moderna pre-pandemic times: Sciences, Platform, and Company History Moderna’s preparation COVID-19. Operations insight for an unprecedented scale-up Execution against the plan. Overcoming challenges Moderna’s future operations — Juan Andres Chief Technical and Quality Officer Moderna As Chief Technical and Quality officer, Juan Andres is responsible for Technical Development, product supply at pre-clinical, clinical and commercial stages and quality across Moderna globally (i.e. CMC); chemistry, manufacturing and controls Mr. Andres was previously the Global Head of Technical Operations (Manufacturing and Supply Chain) for over 25,000 Novartis employees across all of its divisions. In this role, he had responsibility for all of…

Continue reading
Pharmaceutical Development and Manufacturing — The New Post-Pandemic Realities
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Pharmaceutical Development and Manufacturing — The New Post-Pandemic Realities

Discussing how the business model change accelerates Highlighting transformation needs in business setup, technology and ways of working Impact on Development and Manufacturing of different modalities How does Bayer gets prepared for such opportunities and challenges? — Wolfram Carius EVP Pharmaceuticals Bayer AG Prof. Wolfram Carius is the EVP Pharmaceuticals at Bayer AG and is a member of the Executive Committee for Bayer Pharmaceuticals. He is based in Berlin, Germany. Prior to joining Bayer, Wolfram was a corporate senior vice president and member of the global leadership team at Sanofi Genzyme for nearly three years. Before that, he worked for…

Continue reading
Managing Innovation and Variability in a Growth Environment
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Managing Innovation and Variability in a Growth Environment

How the pandemic impacted the structure and responsiveness of our global networks Responding to new geographic fluctuation of demand by disease states and patient delivery The challenges and opportunities posed by new product innovation and managing lifecycles — Linzell Harris SVP Global Supply Chain and Strategy AstraZeneca Linzell Harris is senior vice president of Global Supply Chain and Strategy for AstraZeneca, with overall responsibility for the development and execution of the end to end supply chain platform and product supply strategies. In addition, he is responsible for ensuring the strategic development of network designs and supply chain capabilities supporting the…

Continue reading
COVID-19: What Did We Do, What Have We Learned, and What Has Changed Forever?
HUMAN RESOURCES, HUMAN RESOURCES, VIDEO

COVID-19: What Did We Do, What Have We Learned, and What Has Changed Forever?

Illustrating how HR professionals responded to the novel Corona virus outbreak to guide their organizations through a global pandemic Viewing the crisis as an opportunity to accelerate progress already underway to decentralize and diversify Twitter’s workforce How will the transition back to the office reflect short term and long term changes to how and where we work Is there a way HR leaders can take this experience and use it to continue innovating without the catalyst of a crisis? Jennifer Christie Chief People Officer Twitter Jennifer Christie is Chief People Officer at Twitter. She leads the global People team and…

Continue reading